<DOC>
	<DOCNO>NCT02357459</DOCNO>
	<brief_summary>This study double-blind , randomize , single-dose study ass safety efficacy FX006 treatment pain patient osteoarthritis knee . Approximately 450 patient OA knee randomize one three treatment group ( 1:1:1 ) treat single intra-articular ( IA ) injection : - 40 mg FX006 - 40 mg Triamcinolone Acetonide Injectable Suspension , USP ( refer TCA IR protocol ) - Normal Saline Each patient evaluate total 24 week follow single IA injection . Following screening , safety efficacy evaluate 7 out-patient visit ( Days 1 [ Baseline ] , Weeks 4 , 8 , 12 , 16 , 20 , 24 ) .</brief_summary>
	<brief_title>Study FX006 Treatment Pain Patients With Osteoarthritis Knee</brief_title>
	<detailed_description />
	<mesh_term>Osteoarthritis</mesh_term>
	<mesh_term>Osteoarthritis , Knee</mesh_term>
	<criteria>Willingness ability comply study procedure visit schedule ability follow verbal write instruction Male female &gt; =40 year age Has symptoms associate OA index knee least 6 month prior Screening Currently meet American College Rheumatology ( ACR ) Criteria ( clinical radiological ) OA KellgrenLawrence ( KL ) Grade 2 3 index knee per Screening Xray Index knee pain &gt; 15 day last month Qualifying mean score 24h average pain score ( 010 numeric rating scale ) Body mass index ( BMI ) â‰¤ 40 kg/m2 Willingness abstain use restrict medication Any condition could possibly confound patient 's assessment index knee pain judgement investigator ( i.e. , iIpsilateral hip OA , gout , radicular low back pain hip pain refer knee could cause misclassification , pain area low extremity back equal great index knee pain ) Fibromyalgia , Reiter 's syndrome , rheumatoid arthritis , psoriatic arthritis , ankylose spondylitis , arthritis associate inflammatory bowel disease History infection index knee Clinical sign symptom active knee infection crystal disease index knee within 1 month Screening Unstable joint within 12 month screen IA corticosteroid ( investigational market ) joint within 3 month Screening IA hyaluronic acid ( investigational market ) index knee within 6 month Screening Intramuscular ( IM ) oral corticosteroid ( investigational market ) within 1 month Screening Any IA investigational drug/biologic within 6 month Screening Prior use FX006 Women childbearing potential use effective contraception pregnant nursing</criteria>
	<gender>All</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2017</verification_date>
	<keyword>Osteoarthritis</keyword>
	<keyword>Knee</keyword>
	<keyword>Pain</keyword>
	<keyword>Steroid</keyword>
	<keyword>Intra-articular</keyword>
	<keyword>Injection</keyword>
</DOC>